Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 24, 1947-1951, December 1, 1964]
© 1964 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Block, J. B.
Right arrow Articles by Oliverio, V. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Block, J. B.
Right arrow Articles by Oliverio, V. T.

Cellular Accumulation of Methylglyoxal-bis-guanylhydrazone in Vitro

II. Studies on the Mechanism of Accumulation in Leukemic Leukocytes*

Jerome B. Block, Michael Field and Vincent T. Oliverio

( Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland)

The influence of incubation medium pH on MeGAG uptake into leukemic leukocytes suggests that the cationic form of the drug is transported or bound intracellularly. A large intra- to extracellular potassium gradient is essential to concentrative MeGAG uptake. Preloading leukocytes with MeGAG does not alter subsequent tracer uptake. There is almost no efflux of MeGAG from leukocytes in the cold. Efflux at 37°C. is greater, suggesting active MeGAG extrusion from cells. The data on influx and efflux presented in this report suggest both active membrane transport and intracellular binding of MeGAG.

* Presented in part at the annual meeting of the American Association for Cancer Research, Toronto, Canada, May, 1963, and published in abstract form in Proc. Am. Assoc. Cancer Res., 4:6, 1963.

Received 6/15/64.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1964 by the American Association for Cancer Research.